July Release - 07/05/2022
For additional information about RxNorm releases, including scripts for loading the RxNorm data into Oracle and MySQL databases, read the RxNorm Technical Documentation.
Sources
The following sources with version names in bold have been updated since the previous RxNorm release:
| Source Name | SAB | Version |
|---|---|---|
| DrugBank | DRUGBANK | DRUGBANK5.0_2022_06_02 |
| Gold Standard Drug Database | GS | GS_2022_06_08 |
| Multum MediSource Lexicon | MMSL | MMSL_2022_06_01 |
| Micromedex RED BOOK | MMX | MMX_2022_06_06 |
| FDA Structured Product Labels | MTHSPL | MTHSPL_2022_06_24 |
| FDB MedKnowledge (formerly NDDF Plus) | NDDF | NDDF_2022_06_08 |
| RxNorm normalized names and codes | RXNORM | RXNORM_20AA_220705F |
| Veterans Health Administration National Drug File | VANDF | VANDF_2022_05_31 |
The following sources have not been updated since the previous RxNorm release:
| Source Name | SAB | Version |
|---|---|---|
| Anatomical Therapeutic Chemical Classification System | ATC | ATC_2022 |
| Vaccines Administered | CVX | CVX_2022_04_14 |
| Medical Subject Headings (MeSH) | MSH | MSH2022_2021_07_20 |
| CMS Formulary Reference File | MTHCMSFRF | MTHCMSFRF_2020 |
| US Edition of SNOMED CT (drug information) | SNOMEDCT_US | SNOMEDCT_US_2022_01_31 |
| USP Compendial Nomenclature | USP | USP_2022_2_15 |
*Reminder: As of October 2017, Medi-Span data will not be included in the RxNorm or UMLS releases. If you have questions about Medi-Span, please contact: medispan-support@wolterskluwer.com.
RxNorm Data Changes
New Dose Form "Drug-Eluting Contact Lens" Added
RxNorm includes a new dose form named "Drug-Eluting Contact Lens". This dose form is defined as a contact lens intended for use in the eye that releases a medication.
Here are the fully-specified product name concepts with the new dose form “Drug-Eluting Contact Lens” in the July 2022 release:
| RXCUI | Term Type (TTY) | STRING |
|---|---|---|
| 2604045 | SCD | ketotifen 0.019 MG Drug-Eluting Contact Lens |
| 2604049 | SBD | ketotifen 0.019 MG Drug-Eluting Contact Lens [Acuvue Theravision] |
Lagevrio COVID-19 Medication Concept Added
The molnupiravir COVID-19 medication will be available under the brand name Lagevrio. To reflect this change, a Semantic Branded Drug (SBD) concept for Lagevrio will be in the RxNorm July monthly release.
The National Drug Codes (NDCs) for Lagevrio were previously associated with the generic molnupiravir drug concept. NDCs moved from RXCUI 2587906 to RXCUI 2603740. Get more information about Lagevrio from the FDA.
Here is the new Lagevrio COVID-19 medication concept in RxNorm:
| RXCUI | Term Type (TTY) | STRING |
|---|---|---|
| 2603740 | SBD | molnupiravir 200 MG Oral Capsule [Lagevrio] |
Data Counts
| Term Type or Attribute | Number |
|---|---|
| Active GPCKs | 468 |
| Active BPCKs | 539 |
| Active SCDs | 17178 |
| Active SBDs | 9469 |
| Active RXNORM MINs | 3775 |
| Active RXNORM INs | 13814 |
| Active RXNORM PINs | 3277 |
| Active RXNORM BNs | 5104 |
| Active RXNORM DFs | 122 |
| Obsolete GPCKs | 249 |
| Obsolete BPCKs | 219 |
| Obsolete SCDs | 18735 |
| Obsolete SBDs | 11172 |
| Obsolete RXNORM MINs | 0 |
| Obsolete RXNORM INs | 0 |
| Obsolete RXNORM PINs | 0 |
| Obsolete RXNORM BNs | 6301 |
| Obsolete RXNORM DFs | 63 |
| Editor-suppressed SCDs | 1895 |
| Editor-suppressed SBDs | 1566 |
| SAB=RXNORM NDCs | 243920 |
| Distinct SAB=RXNORM NDCs | 243920 |
Last Reviewed: July 5, 2022